• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早产和足月婴儿中母婴呼吸道合胞病毒和甲型流感病毒抗体的传递

Maternal-Infant Respiratory Syncytial Virus and Influenza A Virus Antibody Transfer in Preterm and Full-term Infants.

作者信息

Rumfelt Kalee E, Pike Mindy, Stolarczuk Jennifer E, Lekander Ava, Lauring Adam S, Eckert Linda O, Englund Janet A, Martin Emily T, Kachikis Alisa B

机构信息

Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA.

Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.

出版信息

Open Forum Infect Dis. 2024 Dec 30;12(1):ofae723. doi: 10.1093/ofid/ofae723. eCollection 2025 Jan.

DOI:10.1093/ofid/ofae723
PMID:39758746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11697169/
Abstract

BACKGROUND

Immunization against influenza and respiratory syncytial virus (RSV) protects pregnant individuals and their infants against infection via transplacental transport of immunoglobulin G (IgG). We sought to evaluate the quantity and efficiency of maternal influenza- and RSV-specific IgG transfer in pregnancies with preterm and full-term deliveries.

METHODS

Delivery samples from 115 maternal-infant pairs (2018-2021) were analyzed for RSV prefusion F and IAV-H3 and IAV-H1 antibodies using electrochemiluminescence assays. We used Wilcoxon rank sum tests, tests, Pearson correlation coefficients (PCCs), and linear regression to evaluate distributions of IgG results by maternal influenza vaccination status and preterm birth (<37 weeks).

RESULTS

Approximately 70% of pregnant persons received influenza vaccine. Maternal and cord antibody concentrations were highest in the influenza-vaccinated group for IAV-H3 and IAV-H1 regardless of preterm birth status (maternal H3, = .004; cord H3, = .03; maternal H1, = .0001; cord H1, = .0002). Preterm infants had significantly lower cord to maternal IgG transfer ratios for IAV-H3 and RSV when compared with full-term infants ( ≤ .05). Correlations between maternal and cord IgG concentrations were significant ( ≤ .001) for all 3 viruses, with the strongest correlation for H3 (PCC: IAV-H3, 0.77; IAV-H1, 0.68; RSV, 0.62). Associations between maternal IgG transfer and preterm birth were significant for IAV-H3 and RSV (IAV-H3, β = -0.42; RSV, β = -0.63; ≤ .05).

CONCLUSIONS

Maternal antibody following vaccination or infection is readily transferred across the placenta. Preterm infants have higher influenza IgG following maternal influenza vaccination and are at highest risk of lower IgG transfer ratios without vaccination.

摘要

背景

接种流感疫苗和呼吸道合胞病毒(RSV)疫苗可通过免疫球蛋白G(IgG)的胎盘转运保护孕妇及其婴儿免受感染。我们试图评估早产和足月分娩的孕妇中,母体流感和RSV特异性IgG转移的数量和效率。

方法

使用电化学发光分析法,对115对母婴(2018 - 2021年)的分娩样本进行RSV预融合F抗体以及IAV - H3和IAV - H1抗体分析。我们使用Wilcoxon秩和检验、检验、Pearson相关系数(PCC)和线性回归,以评估按母体流感疫苗接种状态和早产(<37周)分类的IgG结果分布情况。

结果

约70%的孕妇接种了流感疫苗。无论早产状态如何,接种流感疫苗组的母体和脐带抗体浓度在IAV - H3和IAV - H1方面最高(母体H3,P = 0.004;脐带H3,P = 0.03;母体H1,P = 0.0001;脐带H1,P = 0.0002)。与足月婴儿相比,早产婴儿的IAV - H3和RSV脐带与母体IgG转移率显著更低(P≤0.05)。所有3种病毒的母体和脐带IgG浓度之间均存在显著相关性(P≤0.001),其中H3的相关性最强(PCC:IAV - H3,0.77;IAV - H1,0.68;RSV,0.62)。母体IgG转移与早产之间的关联在IAV - H3和RSV方面显著(IAV - H3,β = -0.42;RSV,β = -0.63;P≤0.05)。

结论

接种疫苗或感染后母体抗体易于通过胎盘转移。早产婴儿在母体接种流感疫苗后具有更高的流感IgG,且在未接种疫苗时IgG转移率降低的风险最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa13/11697169/a0e829b7f265/ofae723f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa13/11697169/8190b8c2c94e/ofae723f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa13/11697169/a0e829b7f265/ofae723f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa13/11697169/8190b8c2c94e/ofae723f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa13/11697169/a0e829b7f265/ofae723f2.jpg

相似文献

1
Maternal-Infant Respiratory Syncytial Virus and Influenza A Virus Antibody Transfer in Preterm and Full-term Infants.早产和足月婴儿中母婴呼吸道合胞病毒和甲型流感病毒抗体的传递
Open Forum Infect Dis. 2024 Dec 30;12(1):ofae723. doi: 10.1093/ofid/ofae723. eCollection 2025 Jan.
2
Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes.孕期接种呼吸道合胞病毒疫苗以改善婴儿结局。
Cochrane Database Syst Rev. 2024 May 2;5(5):CD015134. doi: 10.1002/14651858.CD015134.pub2.
3
Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus.使用呼吸道合胞病毒融合前体蛋白(RSVpreF)对迪拜的私人保险婴儿进行母体疫苗接种以预防呼吸道合胞病毒的预算影响。
Hum Vaccin Immunother. 2025 Dec;21(1):2523106. doi: 10.1080/21645515.2025.2523106. Epub 2025 Jul 2.
4
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
5
Strength and Durability of Respiratory Syncytial Virus Prefusion F Immunoglobulin G Following Infection and Exposure in a Household Cohort, 2014-2022.2014 - 2022年家庭队列中呼吸道合胞病毒预融合F免疫球蛋白G感染和暴露后的强度及耐久性
J Infect Dis. 2025 Jul 11;231(6):e1138-e1145. doi: 10.1093/infdis/jiaf168.
6
Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates.呼吸道合胞病毒疫苗及尼塞韦单抗在孕妇及其新生儿中的接种情况
JAMA Netw Open. 2025 Feb 3;8(2):e2460735. doi: 10.1001/jamanetworkopen.2024.60735.
7
Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine.来自二价呼吸道合胞病毒预融合F蛋白疫苗的MATISSE(安全性和有效性的母体免疫研究)母体试验的早产频率及相关结局
Obstet Gynecol. 2025 Feb 1;145(2):147-156. doi: 10.1097/AOG.0000000000005817. Epub 2025 Jan 2.
8
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.对帕利珠单抗用于呼吸道合胞病毒免疫预防给药依从性的系统评价。
J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. doi: 10.18553/jmcp.2010.16.1.46.
9
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.免疫球蛋白治疗住院婴儿和幼儿呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
10
Adapting COVID-19 research infrastructure to capture influenza and respiratory syncytial virus alongside SARS-CoV-2 in UK healthcare workers winter 2022/23 and beyond: protocol for a pragmatic sub-study.调整新冠病毒研究基础设施,以便在2022/23年冬季及以后在英国医护人员中同时收集流感病毒、呼吸道合胞病毒以及严重急性呼吸综合征冠状病毒2:一项务实子研究的方案
NIHR Open Res. 2024 Nov 5;4:1. doi: 10.3310/nihropenres.13517.2. eCollection 2024.

引用本文的文献

1
Beyond the first breath: comprehensive respiratory syncytial virus prevention through maternal immunization and infant immunoprophylaxis.初呼吸之外:通过母体免疫和婴儿免疫预防实现呼吸道合胞病毒的全面防控
Asian Biomed (Res Rev News). 2025 Jul 28;19(3):116-130. doi: 10.2478/abm-2025-0015. eCollection 2025 Jun.
2
Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1.在一项I期临床试验中,对1至2岁血清反应阳性儿童进行鼻内仙台病毒疫苗接种可增强针对1型人副流感病毒的免疫反应。
Vaccines (Basel). 2025 Apr 19;13(4):430. doi: 10.3390/vaccines13040430.

本文引用的文献

1
Timing of Maternal COVID-19 Vaccine and Antibody Concentrations in Infants Born Preterm.母亲接种 COVID-19 疫苗和抗体浓度在早产儿婴儿中的时间。
JAMA Netw Open. 2024 Jan 2;7(1):e2352387. doi: 10.1001/jamanetworkopen.2023.52387.
2
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计:系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
3
Transplacental transfer of RSV antibody in Australian First Nations infants.
澳大利亚原住民婴儿中 RSV 抗体的胎盘转移。
J Med Virol. 2022 Feb;94(2):782-786. doi: 10.1002/jmv.27383. Epub 2021 Oct 16.
4
Maternal RSV vaccine development. Where to from here?母亲 RSV 疫苗的研发。接下来该怎么做?
Hum Vaccin Immunother. 2021 Nov 2;17(11):4542-4548. doi: 10.1080/21645515.2021.1955608. Epub 2021 Sep 9.
5
Realizing the Potential of Maternal Influenza Vaccination.实现孕产妇流感疫苗接种的潜力
JAMA. 2021 Jun 8;325(22):2257-2259. doi: 10.1001/jama.2021.7776.
6
Efficacy and safety of influenza vaccination during pregnancy: realizing the potential of maternal influenza immunization.妊娠期流感疫苗接种的效果和安全性:实现母亲流感免疫的潜力。
Expert Rev Vaccines. 2021 Jun;20(6):649-660. doi: 10.1080/14760584.2021.1915138. Epub 2021 Apr 22.
7
Infant immunity against viral infections is advanced by the placenta-dependent vertical transfer of maternal antibodies.婴儿对病毒感染的免疫力是通过胎盘依赖的垂直传递母体抗体来实现的。
Vaccine. 2022 Mar 8;40(11):1563-1571. doi: 10.1016/j.vaccine.2020.12.049. Epub 2021 Jan 9.
8
Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials.妊娠期流感疫苗接种的疗效、保护持续时间、母婴结局和婴儿生长情况:三项随机对照试验的汇总分析。
Lancet Respir Med. 2020 Jun;8(6):597-608. doi: 10.1016/S2213-2600(19)30479-5.
9
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222.妊娠期高血压与子痫前期:ACOG 实践通报摘要,第 222 号。
Obstet Gynecol. 2020 Jun;135(6):1492-1495. doi: 10.1097/AOG.0000000000003892.
10
Transplacental Respiratory Syncytial Virus and Influenza Virus Antibody Transfer in Alaska Native and Seattle Mother-Infant Pairs.阿拉斯加原住民和西雅图母婴对之间胎盘呼吸合胞病毒和流感病毒抗体的转移。
J Pediatric Infect Dis Soc. 2021 Apr 3;10(3):230-236. doi: 10.1093/jpids/piaa040.